Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study

@inproceedings{Lin2015FluoroquinolonesV,
  title={Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study},
  author={Kuan-Yin Lin and Chi-Chuan Wang and Chia-Hui Lin and Wang-Huei Sheng and Shan-Chwen Chang and Philip M. Short},
  booktitle={PloS one},
  year={2015}
}
BACKGROUND Studies on the association between antibiotic treatment and outcomes in outpatients with chronic obstructive pulmonary disease (COPD) and pneumonia are scarce. This study aimed to evaluate the effectiveness of fluoroquinolones and β-lactam/β-lactamase inhibitors for pneumonia in COPD outpatients. METHODS We conducted a retrospective cohort study and identified 4,851 episodes of pneumonia among COPD outpatients treated with fluoroquinolones or β-lactam/β-lactamase inhibitors from… CONTINUE READING
1
Twitter Mention

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Role of infections.

  • Clinics in chest medicine
  • 2014